OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells is a paramount challenge to the biopharmaceutical industry. Multiple strategies are employed to antibody titer, such as process parameter optimization, media optimization, and the use of perfusion systems. Fine-tuning media composition plays a crucial role in